Catalyst Wire Dossier Catalyst Wire Dossier

Bi-Profenid 200mg

· Sanofi
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bi-Profenid 200mg, covering 2009-09-25 to 2009-09-25. Get the full timeline:

Most recent: Clinical Trial Update: Study of Non Inferiority Bi-Profenid® 200mg Versus Bi-Profenid® 300mg Among Patients Presenting of the Post-traumatic or Rheumatologic Acute Affections of the Locomotor Apparatus (BIPROPAIN) [Phase 3]

See pricing